Copper blocks quinolinic acid neurotoxicity in rats: Contribution of antioxidant systems
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Reactive oxygen species and oxidative stress are involved in quinolinic acid (QUIN)-induced neurotoxicity. QUIN, a N-methyl-D-aspartate receptor (NMDAr) agonist and prooxidant molecule, produces NMDAr overactivation, excitotoxic events, and direct reactive oxygen species formation. Copper is an essential metal exhibiting both modulatory effects on neuronal excitatory activity and antioxidant properties. To investigate whether this metal is able to counteract the neurotoxic and oxidative actions of QUIN, we administered copper (as CuSO4) intraperitoneally to rats (2.5, 5.0, 7.5, and 10.0 mg/kg) 30 min before the striatal infusion of 1 μl of QUIN (240 nmol). A 5.0 mg/kg CuSO4 dose significantly increased the copper content in the striatum, reduced the neurotoxicity measured both as circling behavior and striatal γ-aminobutyric acid (GABA) depletion, and blocked the oxidative injury evaluated as striatal lipid peroxidation (LP). In addition, copper reduced the QUIN-induced decreased striatal activity of Cu,Zn-dependent superoxide dismutase, and increased the ferroxidase activity of ceruloplasmin in cerebrospinal fluid from QUIN-treated rats. However, copper also produced significant increases of plasma lactate dehydrogenase activity and mortality at the highest doses employed (7.5 and 10.0 mg/kg). These results show that at low doses, copper exerts a protective effect on in vivo QUIN neurotoxicity. © 2003 Elsevier Inc.
publication date
funding provided via
published in
Research
keywords
-
Copper sulfate; Free radicals; Neurotoxicity; NMDA receptor; Oxidative stress; Quinolinic acid; Rat striatum 4 aminobutyric acid; ceruloplasmin; copper sulfate; lactate dehydrogenase; quinolinic acid; superoxide dismutase; animal experiment; animal model; animal tissue; antioxidant activity; article; cerebrospinal fluid; circling behavior; controlled study; corpus striatum; depletion; dose response; drug effect; drug megadose; enzyme activity; enzyme assay; in vivo study; lactate dehydrogenase blood level; lipid peroxidation; low drug dose; male; mortality; neuroprotection; neurotoxicity; nonhuman; oxidation; priority journal; rat; treatment outcome
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue